Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1285.6 -39 (-2.94%) Market Cap: 118.30 Bil Enterprise Value: 140.57 Bil PE Ratio: 2,436.55 PB Ratio: 5.59 GF Score: 74/100

Q2 2022 Strides Pharma Science Ltd Earnings Call Transcript

Nov 10, 2021 / 10:30AM GMT
Release Date Price: ā‚¹504.1 (-8.52%)
Operator

Ladies and gentlemen, good day, and welcome to the Q2 and H1 FY '22 Earnings Conference Call of Strides Pharma Science Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Abhishek Singhal. Thank you, and over to you, sir.

Abhishek Singhal

A very good afternoon, and thank you for joining us today for Strides earnings call for the second quarter and half year ended financial year 2022. Today, we have with us Arun, Founder and Non-Executive Chairman; Dr. Ananth, Managing Director and CEO; and Badree, Executive Director in Finance and Group CFO, to share the highlights of the business and financials for the quarter.

I hope you have gone through our business release and the quarterly investor presentation, which have been uploaded on our website as well as the stock exchange website. The transcript for this call will be available in a week's time on the company's website.

Please note that today's discussion may be forward-looking in nature and must be viewed in relation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot